Alexander Kristen
Insider CIK 1878867 · LXRX VP, Finance and Accounting
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2025-02-28 | 2025-03-03 | 15,926 | — | $0 | 15,927 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2025-02-28 | 2025-03-03 | 10,617 | — | $0 | 0 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2025-02-28 | 2025-03-03 | 19,887 | — | $0 | 39,773 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | F Tax w/h | 2025-02-28 | 2025-03-03 | 17,862 | $0.67 | $12.0K | 76,368 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2025-02-28 | 2025-03-03 | 19,887 | — | $0 | 94,230 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2025-02-28 | 2025-03-03 | 15,926 | — | $0 | 74,343 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2025-02-28 | 2025-03-03 | 10,617 | — | $0 | 58,417 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award deriv | 2025-02-13 | 2025-02-18 | 185,540 | — | $0 | 185,540 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award deriv | 2025-02-13 | 2025-02-18 | 185,540 | — | $0 | 185,540 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2024-02-28 | 2024-02-29 | 2,700 | — | $0 | 0 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2024-02-28 | 2024-02-29 | 10,616 | — | $0 | 10,617 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2024-02-28 | 2024-02-29 | 15,927 | — | $0 | 31,853 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2024-02-28 | 2024-02-29 | 15,927 | — | $0 | 59,593 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2024-02-28 | 2024-02-29 | 2,700 | — | $0 | 33,050 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2024-02-28 | 2024-02-29 | 10,616 | — | $0 | 43,666 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | F Tax w/h | 2024-02-28 | 2024-02-29 | 11,793 | $2.62 | $30.9K | 47,800 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award deriv | 2024-02-08 | 2024-02-12 | 59,660 | — | $0 | 59,660 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award deriv | 2024-02-08 | 2024-02-12 | 59,660 | — | $0 | 59,660 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2023-02-28 | 2023-03-01 | 2,700 | — | $0 | 2,700 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2023-02-28 | 2023-03-01 | 5,400 | — | $0 | 0 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2023-02-28 | 2023-03-01 | 10,617 | — | $0 | 21,233 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2023-02-28 | 2023-03-01 | 10,617 | — | $0 | 35,680 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | F Tax w/h | 2023-02-28 | 2023-03-01 | 5,330 | $2.17 | $11.6K | 30,350 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2023-02-28 | 2023-03-01 | 2,700 | — | $0 | 25,063 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2023-02-28 | 2023-03-01 | 5,400 | — | $0 | 22,363 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award deriv | 2023-02-09 | 2023-02-13 | 71,670 | — | $0 | 71,670 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award deriv | 2023-02-09 | 2023-02-13 | 47,780 | — | $0 | 47,780 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2022-02-28 | 2022-02-28 | 3,200 | — | $0 | 0 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2022-02-28 | 2022-02-28 | 5,400 | — | $0 | 5,400 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2022-02-28 | 2022-02-28 | 2,700 | — | $0 | 5,400 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | F Tax w/h | 2022-02-28 | 2022-02-28 | 3,337 | $2.85 | $9.5K | 16,963 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2022-02-28 | 2022-02-28 | 2,700 | — | $0 | 20,300 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2022-02-28 | 2022-02-28 | 5,400 | — | $0 | 17,600 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2022-02-28 | 2022-02-28 | 3,200 | — | $0 | 12,200 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award deriv | 2022-02-10 | 2022-02-14 | 31,850 | — | $0 | 31,850 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award deriv | 2022-02-10 | 2022-02-14 | 47,780 | — | $0 | 47,780 | SEC↗ |